Omnicare (NYSE: OCR) reported earnings on July 24. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), Omnicare beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased slightly. Non-GAAP earnings per share expanded significantly. GAAP earnings per share increased significantly.

Gross margins grew, operating margins dropped, net margins expanded.

Revenue details
 Omnicare booked revenue of $1.57 billion. The seven analysts polled by S&P Capital IQ expected to see sales of $1.54 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.90. The eight earnings estimates compiled by S&P Capital IQ anticipated $0.87 per share. Non-GAAP EPS of $0.90 for Q2 were 43% higher than the prior-year quarter's $0.63 per share. GAAP EPS of $0.48 for Q2 were 182% higher than the prior-year quarter's $0.17 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 24.1%, 20 basis points better than the prior-year quarter. Operating margin was 7.3%, 190 basis points worse than the prior-year quarter. Net margin was 3.3%, 210 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $1.53 billion. On the bottom line, the average EPS estimate is $0.88.

Next year's average estimate for revenue is $6.14 billion. The average EPS estimate is $3.56.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 221 members out of 241 rating the stock outperform, and 20 members rating it underperform. Among 93 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 91 give Omnicare a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omnicare is outperform, with an average price target of $48.88.

Is Omnicare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.